About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

Biotechnology Law Report

Editor-in-Chief: Gerry J. Elman

Executive Editor: Christopher M. Holman

ISSN: 0730-031X • Published Bimonthly • Online ISSN: 1557-8704

Current Volume: 32

Open Access Options for this Peer-Reviewed Journal

 

Benefits of Liebert Open Access:

Authors and research funders who chose to have their original research articles posted free online with immediate, unrestricted Open Access (OA) pay a one-time $3,200 article processing charge (APC). This article OA investment ensures the widest visibility, discoverability, and application of the funded research. Institutions and funders may support OA for their researchers by participating in the Liebert Author Advocacy Program (LAAP) which entitles authors to a 25% reduction of APC charges on articles published in Liebert journals.

OA Author benefits include:

  • Fast track ONLINE publication and deposit to internationally recognized repositories (such as PubMedCentral*)
  • Universally and freely available article access via the Internet
  • Article recognition on TOC with OA icon and proper attribution of authorship, source, and full citation details
  • Targeted email marketing announcement highlighting OA article
  • Compliance with OA funding mandates with no embargo period
  • Increased visibility - readership, citations, downloads

LAAP Author benefits:

Authors whose institutions are members of the LAAP program receive all OA benefits above at a 25% reduction of APC fee, as well as enhanced marketing and author networking services through the AuthorCite program. AuthorCite charter membership is complimentary for LAAP participants, and provides extended author services including:

  • Personalized author profile and microsite
  • Manuscript submission and article tracking service
  • Article citation tracking tool and metrics
  • Author CV and contact management tool
  • OpenLink™ article research sharing

Contact openaccess@liebertpub.com for questions on article Open Access options.
Contact laap@liebertpub.com to learn more about LAAP participation benefits.
Contact authorcite@liebertpub.com to learn more about AuthorCite™ services.

The Liebert Open Access program supports global OA research mandates from leading funding bodies including the NIH, Wellcome Trust and HHMI among others.

 

*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Genetic Engineering & Biotechnology News

    Genetic Engineering & Biotechnology News

    Industrial Biotechnology

    Industrial Biotechnology

    The authoritative, peer-reviewed bimonthly research journal focused on biobased industrial and environmental products and processes reporting the science, business, and policy developments of the emerging global bioeconomy.

    ASSAY and Drug Development Technologies

    ASSAY and Drug Development Technologies

    This authoritative, rapidly peer-reviewed journal features original articles, application-oriented technology reviews, and reports in methodology and technology application.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Cellular Reprogramming

    Cellular Reprogramming

    formerly Cloning and Stem Cells

    Cutting-edge techniques and the latest high-quality research on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

Browse All Publications »